CLINICAL_TRIALS
trial_result
· 2021-04-21
Clinical Trial Update: Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP [Phase 2]
Summary
Phase 2 trial evaluating denosumab to prevent bone loss after teriparatide in premenopausal women with adult idiopathic generalized osteoporosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Elizabeth Shane | Conditions: Adult Idiopathic Generalized Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2021-04-21